Compare TNYA & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TNYA | GORO |
|---|---|---|
| Founded | 2016 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Precious Metals |
| Sector | Health Care | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 178.5M | 212.0M |
| IPO Year | 2021 | 2010 |
| Metric | TNYA | GORO |
|---|---|---|
| Price | $0.79 | $1.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 2 |
| Target Price | ★ $5.33 | $1.63 |
| AVG Volume (30 Days) | ★ 2.8M | 1.8M |
| Earning Date | 05-06-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 54.96 | ★ 91.80 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $99,759,000.00 |
| Revenue This Year | N/A | $25.99 |
| Revenue Next Year | N/A | $5.78 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 51.78 |
| 52 Week Low | $0.36 | $0.35 |
| 52 Week High | $2.35 | $1.87 |
| Indicator | TNYA | GORO |
|---|---|---|
| Relative Strength Index (RSI) | 56.66 | 64.17 |
| Support Level | $0.64 | $0.79 |
| Resistance Level | $0.82 | $1.75 |
| Average True Range (ATR) | 0.05 | 0.10 |
| MACD | 0.01 | 0.05 |
| Stochastic Oscillator | 87.27 | 82.10 |
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Gold Resource Corp is a producer of metal concentrates that contain gold, silver, copper, lead, and zinc in Oaxaca, Mexico. . It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America. The Company has two reporting segments, based on geographic regions. Oaxaca, Mexico represents the Company's only operating segment with a production stage property. The Company's other reporting segment is Michigan, U.S.A., with an exploration stage property.